Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayanti Mukherjee

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Diabetes Care|August 23, 2018
Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 DiabetesUrvi Desai, Noam Y Kirson, Jennifer Kim, et al.
Arzneimittel-Forschung|March 2, 2011
Bioequivalence study of levofloxacin tablets in healthy Indian volunteers using HPLCAyan Das, Jayanti Mukherjee, Goutam Dey, et al.
Lipids in Health and Disease|February 12, 2005
Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDSAdrian R Levy, Lawrence McCandless, P Richard Harrigan, et al.
Diabetes, Obesity & Metabolism|February 18, 2017
Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: An individual patient simulation studyHenry J Folse, Jayanti Mukherjee, John J Sheehan, et al.
Diabetes Research and Clinical Practice|May 30, 2017
Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trialAndrew H Briggs, Deepak L Bhatt, Benjamin M Scirica, et al.
Diabetes Care|May 22, 2016
Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart StudyNathan D Wong, Yanglu Zhao, Rohini Patel, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Diabetes Care|August 23, 2018
Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 DiabetesUrvi Desai, Noam Y Kirson, Jennifer Kim, et al.
Arzneimittel-Forschung|March 2, 2011
Bioequivalence study of levofloxacin tablets in healthy Indian volunteers using HPLCAyan Das, Jayanti Mukherjee, Goutam Dey, et al.
Lipids in Health and Disease|February 12, 2005
Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDSAdrian R Levy, Lawrence McCandless, P Richard Harrigan, et al.
Diabetes, Obesity & Metabolism|February 18, 2017
Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: An individual patient simulation studyHenry J Folse, Jayanti Mukherjee, John J Sheehan, et al.
Diabetes Research and Clinical Practice|May 30, 2017
Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trialAndrew H Briggs, Deepak L Bhatt, Benjamin M Scirica, et al.
Diabetes Care|May 22, 2016
Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart StudyNathan D Wong, Yanglu Zhao, Rohini Patel, et al.
Pageof 3